Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Trypanosoma brucei brucei strain:427

ABSTRACT: The RNA-binding protein RBP42 regulates cellular energy metabolism in mammalian-infective Trypanosoma brucei

PROVIDER: PRJNA734911 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14768800.fastq.gz	Fastqsanger.gz
	SRR14768801.fastq.gz	Fastqsanger.gz
	SRR14768802.fastq.gz	Fastqsanger.gz
	SRR14768803.fastq.gz	Fastqsanger.gz
	SRR14768804.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Transcriptome analysis of two life cycle stages of Trypanosoma brucei gambiense

2010-07-22 | GSE18065 | GEO

Trypanosoma brucei brucei strain:Lister 427

Project description:Trypanosoma brucei brucei strain:Lister 427 Targeted Locus (Loci)

| PRJNA247996 | ENA

Trypanosoma brucei brucei strain:Lister 427

Project description:Trypanosoma brucei brucei strain:Lister 427 Raw sequence reads

| PRJNA296500 | ENA

Trypanosoma brucei brucei strain:Lister 427

Project description:Trypanosoma brucei brucei strain:Lister 427 Transcriptome or Gene expression

| PRJNA248941 | ENA

Trypanosoma brucei brucei strain:Lister 427

Project description:Trypanosoma brucei brucei VSG-seq 70-bp repeat mutant analysis

| PRJNA292027 | ENA

Trypanosoma brucei brucei strain:Lister 427

Project description:Trypanosoma brucei brucei strain:Lister 427 Transcriptome or Gene expression

| PRJNA255753 | ENA

Digital Gene Expression data of a group 1 Trypanosoma brucei gambiense vs a Trypanosoma brucei brucei

Project description:Trypanosoma brucei gambiense is the causative agent of the fatal human disease African sleeping sickness. Using Digital Gene Expression we have compared the transcriptome of a group 1 T.b.gambiense (Eliane) and a T.b.brucei (STIB 247).

2022-08-31 | GSE23885 | GEO

Trypanosoma brucei strain:Lister 427

Project description:Mathematical modeling of Trypanosoma brucei transcription

| PRJNA315042 | ENA

Transcriptome analysis of two life cycle stages of Trypanosoma brucei gambiense

Project description:Trypanosoma brucei gambiense is the causative agent of the fatal human disease African sleeping sickness. Here we have compared the transcriptome of two different life cycle stages, the potentially human-infective bloodstream form and the non-human-infective procyclic stage, using digital gene expression (DGE) analysis. Digital gene expression analysis was performed on RNA from 3 biological replicates of bloodstream cultured T.b. gambiense strain STIB 386 and compared to that from 3 biological replicates of procyclic cultured T.b. gambiense strain STIB 386.

2010-07-21 | E-GEOD-18065 | biostudies-arrayexpress

Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole

Project description:Purpose: Acoziborole is a recently developed benzoxaborole class compound, currently in clinical trials, for stage 1 and stage 2 treatment of Human African Trypanosomiasis. Recent studies have made significant progress in determining the molecular mode of action of acoziborole. However, less is known about the potential mechanisms leading to acoziborole resistance in trypanosomes. By characterising in vitro drug-resistance, this study aimed to gain a better understanding of the mechanisms involved in acoziborole resistance in the clinicaly relevant Trypanosoma brucei Methods: Drug resistance was generated in vitro through incremental dosage of acoziborole. RNA was isolated from axenic cultures of drug-resistant and parental drug sensitive cells and submitted for RNA-seq Results: Transcriptomics analysis revealed widepread downregulation of transcripts associated with mammalian-infective bloodstream-form parasites. Conversely, transcripts associated with insect-stage procyclic form parasites were increased, indicating that the resistant cells had undergone an unspecified "differentiation event", albeit on a transcriptomic level Conclusions: Trypanosoma brucei resistance to acoziborole can be generated under in vitro axenic conditions, and "transcriptional differentiation" is a mechanism of resistance. However, it is unknown whether this phenomenon is relevant to an in vivo setting

2021-03-07 | GSE168394 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data